UniProt ID | PDLI1_HUMAN | |
---|---|---|
UniProt AC | O00151 | |
Protein Name | PDZ and LIM domain protein 1 | |
Gene Name | PDLIM1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 329 | |
Subcellular Localization | Cytoplasm . Cytoplasm, cytoskeleton . Cytoplasm, myofibril, sarcomere, Z line . Associates with actin stress fibers. | |
Protein Description | Cytoskeletal protein that may act as an adapter that brings other proteins (like kinases) to the cytoskeleton. [PubMed: 10861853 Involved in assembly, disassembly and directioning of stress fibers in fibroblasts. Required for the localization of ACTN1 and PALLD to stress fibers. Required for cell migration and in maintaining cell polarity of fibroblasts (By similarity] | |
Protein Sequence | MTTQQIDLQGPGPWGFRLVGGKDFEQPLAISRVTPGSKAALANLCIGDVITAIDGENTSNMTHLEAQNRIKGCTDNLTLTVARSEHKVWSPLVTEEGKRHPYKMNLASEPQEVLHIGSAHNRSAMPFTASPASSTTARVITNQYNNPAGLYSSENISNFNNALESKTAASGVEANSRPLDHAQPPSSLVIDKESEVYKMLQEKQELNEPPKQSTSFLVLQEILESEEKGDPNKPSGFRSVKAPVTKVAASIGNAQKLPMCDKCGTGIVGVFVKLRDRHRHPECYVCTDCGTNLKQKGHFFVEDQIYCEKHARERVTPPEGYEVVTVFPK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MTTQQIDLQ ------CCCEEEECC | 33.06 | 22814378 | |
2 | Phosphorylation | ------MTTQQIDLQ ------CCCEEEECC | 33.06 | 28857561 | |
3 | Phosphorylation | -----MTTQQIDLQG -----CCCEEEECCC | 19.71 | 28857561 | |
22 | Acetylation | GFRLVGGKDFEQPLA CEEEECCCCCCCCEE | 54.00 | 26051181 | |
22 | Ubiquitination | GFRLVGGKDFEQPLA CEEEECCCCCCCCEE | 54.00 | 21890473 | |
22 | 2-Hydroxyisobutyrylation | GFRLVGGKDFEQPLA CEEEECCCCCCCCEE | 54.00 | - | |
31 | Phosphorylation | FEQPLAISRVTPGSK CCCCEEEEEECCCCH | 18.32 | 20068231 | |
34 | Phosphorylation | PLAISRVTPGSKAAL CEEEEEECCCCHHHH | 22.33 | 22199227 | |
37 | Phosphorylation | ISRVTPGSKAALANL EEEECCCCHHHHHHH | 21.96 | 26270265 | |
61 | Sulfoxidation | DGENTSNMTHLEAQN CCCCCCCCCHHHHHH | 2.21 | 30846556 | |
71 | Ubiquitination | LEAQNRIKGCTDNLT HHHHHHHCCCCCCEE | 44.70 | - | |
71 | Malonylation | LEAQNRIKGCTDNLT HHHHHHHCCCCCCEE | 44.70 | 26320211 | |
71 | Acetylation | LEAQNRIKGCTDNLT HHHHHHHCCCCCCEE | 44.70 | 26051181 | |
73 | Glutathionylation | AQNRIKGCTDNLTLT HHHHHCCCCCCEEEE | 3.52 | 22555962 | |
73 | S-nitrosylation | AQNRIKGCTDNLTLT HHHHHCCCCCCEEEE | 3.52 | 22178444 | |
78 | Phosphorylation | KGCTDNLTLTVARSE CCCCCCEEEEEECCC | 27.00 | 27251275 | |
80 | Phosphorylation | CTDNLTLTVARSEHK CCCCEEEEEECCCCC | 13.59 | 27251275 | |
84 | Phosphorylation | LTLTVARSEHKVWSP EEEEEECCCCCEECC | 34.02 | 25106551 | |
87 | Methylation | TVARSEHKVWSPLVT EEECCCCCEECCEEC | 41.15 | - | |
87 | Ubiquitination | TVARSEHKVWSPLVT EEECCCCCEECCEEC | 41.15 | - | |
90 | Phosphorylation | RSEHKVWSPLVTEEG CCCCCEECCEECCCC | 16.02 | 19664994 | |
94 | O-linked_Glycosylation | KVWSPLVTEEGKRHP CEECCEECCCCCCCC | 35.68 | 55821493 | |
94 | Phosphorylation | KVWSPLVTEEGKRHP CEECCEECCCCCCCC | 35.68 | 23927012 | |
98 | Malonylation | PLVTEEGKRHPYKMN CEECCCCCCCCCCCC | 51.30 | 26320211 | |
98 | 2-Hydroxyisobutyrylation | PLVTEEGKRHPYKMN CEECCCCCCCCCCCC | 51.30 | - | |
98 | Acetylation | PLVTEEGKRHPYKMN CEECCCCCCCCCCCC | 51.30 | 25953088 | |
98 | Ubiquitination | PLVTEEGKRHPYKMN CEECCCCCCCCCCCC | 51.30 | - | |
102 | Phosphorylation | EEGKRHPYKMNLASE CCCCCCCCCCCCCCC | 19.42 | 27259358 | |
104 | Sulfoxidation | GKRHPYKMNLASEPQ CCCCCCCCCCCCCCC | 4.02 | 30846556 | |
108 | O-linked_Glycosylation | PYKMNLASEPQEVLH CCCCCCCCCCCEEEE | 53.64 | 30059200 | |
108 | Phosphorylation | PYKMNLASEPQEVLH CCCCCCCCCCCEEEE | 53.64 | 20068231 | |
118 | Phosphorylation | QEVLHIGSAHNRSAM CEEEECCCCCCCCCC | 26.25 | 23401153 | |
123 | Phosphorylation | IGSAHNRSAMPFTAS CCCCCCCCCCCCCCC | 33.95 | 23927012 | |
125 | Sulfoxidation | SAHNRSAMPFTASPA CCCCCCCCCCCCCCC | 2.71 | 21406390 | |
128 | O-linked_Glycosylation | NRSAMPFTASPASST CCCCCCCCCCCCCCC | 21.98 | 30059200 | |
128 | Phosphorylation | NRSAMPFTASPASST CCCCCCCCCCCCCCC | 21.98 | 23927012 | |
130 | Phosphorylation | SAMPFTASPASSTTA CCCCCCCCCCCCCCE | 20.24 | 23927012 | |
133 | Phosphorylation | PFTASPASSTTARVI CCCCCCCCCCCEEEE | 31.44 | 23927012 | |
134 | O-linked_Glycosylation | FTASPASSTTARVIT CCCCCCCCCCEEEEE | 31.70 | 30059200 | |
134 | Phosphorylation | FTASPASSTTARVIT CCCCCCCCCCEEEEE | 31.70 | 23927012 | |
135 | O-linked_Glycosylation | TASPASSTTARVITN CCCCCCCCCEEEEEC | 23.21 | OGP | |
135 | Phosphorylation | TASPASSTTARVITN CCCCCCCCCEEEEEC | 23.21 | 23927012 | |
136 | O-linked_Glycosylation | ASPASSTTARVITNQ CCCCCCCCEEEEECC | 17.89 | OGP | |
136 | Phosphorylation | ASPASSTTARVITNQ CCCCCCCCEEEEECC | 17.89 | 23927012 | |
141 | Phosphorylation | STTARVITNQYNNPA CCCEEEEECCCCCCC | 17.26 | 21945579 | |
144 | Phosphorylation | ARVITNQYNNPAGLY EEEEECCCCCCCCCC | 20.98 | 21945579 | |
151 | Phosphorylation | YNNPAGLYSSENISN CCCCCCCCCCCCHHH | 14.83 | 21945579 | |
152 | Phosphorylation | NNPAGLYSSENISNF CCCCCCCCCCCHHHH | 35.90 | 21945579 | |
153 | Phosphorylation | NPAGLYSSENISNFN CCCCCCCCCCHHHHH | 22.55 | 21945579 | |
157 | Phosphorylation | LYSSENISNFNNALE CCCCCCHHHHHHHHH | 47.12 | 21945579 | |
167 | Phosphorylation | NNALESKTAASGVEA HHHHHHHHHHCCCCC | 36.41 | 28857561 | |
170 | Phosphorylation | LESKTAASGVEANSR HHHHHHHCCCCCCCC | 40.69 | 28857561 | |
176 | Phosphorylation | ASGVEANSRPLDHAQ HCCCCCCCCCCCCCC | 42.18 | 28857561 | |
186 | Phosphorylation | LDHAQPPSSLVIDKE CCCCCCCCCEEEECH | 42.88 | 17287340 | |
187 | Phosphorylation | DHAQPPSSLVIDKES CCCCCCCCEEEECHH | 32.22 | 17287340 | |
192 | Acetylation | PSSLVIDKESEVYKM CCCEEEECHHHHHHH | 52.60 | 26051181 | |
192 | 2-Hydroxyisobutyrylation | PSSLVIDKESEVYKM CCCEEEECHHHHHHH | 52.60 | - | |
192 | Ubiquitination | PSSLVIDKESEVYKM CCCEEEECHHHHHHH | 52.60 | - | |
194 | Phosphorylation | SLVIDKESEVYKMLQ CEEEECHHHHHHHHH | 37.80 | 29978859 | |
197 | Phosphorylation | IDKESEVYKMLQEKQ EECHHHHHHHHHHHH | 6.14 | 25394399 | |
198 | 2-Hydroxyisobutyrylation | DKESEVYKMLQEKQE ECHHHHHHHHHHHHH | 38.01 | - | |
198 | Ubiquitination | DKESEVYKMLQEKQE ECHHHHHHHHHHHHH | 38.01 | - | |
203 | Ubiquitination | VYKMLQEKQELNEPP HHHHHHHHHHHCCCC | 35.79 | - | |
203 | 2-Hydroxyisobutyrylation | VYKMLQEKQELNEPP HHHHHHHHHHHCCCC | 35.79 | - | |
211 | Ubiquitination | QELNEPPKQSTSFLV HHHCCCCCCCHHHHH | 68.54 | - | |
213 | Phosphorylation | LNEPPKQSTSFLVLQ HCCCCCCCHHHHHHH | 31.95 | 28450419 | |
214 | Phosphorylation | NEPPKQSTSFLVLQE CCCCCCCHHHHHHHH | 22.47 | 28450419 | |
215 | Phosphorylation | EPPKQSTSFLVLQEI CCCCCCHHHHHHHHH | 23.10 | 28102081 | |
233 | Ubiquitination | EEKGDPNKPSGFRSV HHCCCCCCCCCCCCC | 46.04 | - | |
233 | Acetylation | EEKGDPNKPSGFRSV HHCCCCCCCCCCCCC | 46.04 | 26051181 | |
235 | Phosphorylation | KGDPNKPSGFRSVKA CCCCCCCCCCCCCCC | 52.77 | 25056879 | |
239 | Phosphorylation | NKPSGFRSVKAPVTK CCCCCCCCCCCCHHH | 26.21 | 25056879 | |
241 | Ubiquitination | PSGFRSVKAPVTKVA CCCCCCCCCCHHHHH | 48.49 | - | |
241 | Acetylation | PSGFRSVKAPVTKVA CCCCCCCCCCHHHHH | 48.49 | 25953088 | |
245 | Phosphorylation | RSVKAPVTKVAASIG CCCCCCHHHHHHHHC | 20.81 | 26074081 | |
246 | Acetylation | SVKAPVTKVAASIGN CCCCCHHHHHHHHCC | 30.06 | 25953088 | |
246 | Ubiquitination | SVKAPVTKVAASIGN CCCCCHHHHHHHHCC | 30.06 | - | |
250 | Phosphorylation | PVTKVAASIGNAQKL CHHHHHHHHCCHHCC | 22.69 | 26657352 | |
256 | Ubiquitination | ASIGNAQKLPMCDKC HHHCCHHCCCCCCCC | 52.74 | - | |
262 | 2-Hydroxyisobutyrylation | QKLPMCDKCGTGIVG HCCCCCCCCCCCEEE | 29.63 | - | |
283 | Glutathionylation | DRHRHPECYVCTDCG CCCCCCCEEEECCCC | 3.48 | 22555962 | |
284 | Phosphorylation | RHRHPECYVCTDCGT CCCCCCEEEECCCCC | 9.26 | 30108239 | |
287 | Phosphorylation | HPECYVCTDCGTNLK CCCEEEECCCCCCCE | 25.04 | 30108239 | |
291 | Phosphorylation | YVCTDCGTNLKQKGH EEECCCCCCCEECCC | 43.65 | 26657352 | |
296 | Acetylation | CGTNLKQKGHFFVED CCCCCEECCCEEECC | 53.41 | 26051181 | |
306 | Phosphorylation | FFVEDQIYCEKHARE EEECCCEEEHHHHHH | 6.74 | 28152594 | |
309 | Ubiquitination | EDQIYCEKHARERVT CCCEEEHHHHHHCCC | 38.72 | - | |
309 | Acetylation | EDQIYCEKHARERVT CCCEEEHHHHHHCCC | 38.72 | 25953088 | |
316 | Phosphorylation | KHARERVTPPEGYEV HHHHHCCCCCCCCEE | 39.07 | 21945579 | |
321 | Nitration | RVTPPEGYEVVTVFP CCCCCCCCEEEEEEC | 12.14 | - | |
321 | Phosphorylation | RVTPPEGYEVVTVFP CCCCCCCCEEEEEEC | 12.14 | 21945579 | |
325 | Phosphorylation | PEGYEVVTVFPK--- CCCCEEEEEECC--- | 22.93 | 21945579 | |
325 | O-linked_Glycosylation | PEGYEVVTVFPK--- CCCCEEEEEECC--- | 22.93 | 30059200 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PDLI1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PDLI1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PDLI1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
STK35_HUMAN | STK35 | physical | 11973348 | |
ACTN1_HUMAN | ACTN1 | physical | 10753915 | |
ACTN4_HUMAN | ACTN4 | physical | 10753915 | |
RNF12_HUMAN | RLIM | physical | 19117995 | |
PDLI1_HUMAN | PDLIM1 | physical | 19117995 | |
ESR1_HUMAN | ESR1 | physical | 19117995 | |
PNPT1_HUMAN | PNPT1 | physical | 22939629 | |
ARI2_HUMAN | ARIH2 | physical | 22863883 | |
HXK2_HUMAN | HK2 | physical | 22863883 | |
NUBP1_HUMAN | NUBP1 | physical | 22863883 | |
ACTN4_HUMAN | ACTN4 | physical | 26186194 | |
ACTN1_HUMAN | ACTN1 | physical | 26186194 | |
ACTN2_HUMAN | ACTN2 | physical | 26186194 | |
ACTN3_HUMAN | ACTN3 | physical | 26186194 | |
NUD12_HUMAN | NUDT12 | physical | 26186194 | |
MOG1_HUMAN | RANGRF | physical | 26186194 | |
STMN1_HUMAN | STMN1 | physical | 26344197 | |
ACTN3_HUMAN | ACTN3 | physical | 28514442 | |
NUD12_HUMAN | NUDT12 | physical | 28514442 | |
ACTN1_HUMAN | ACTN1 | physical | 28514442 | |
ACTN2_HUMAN | ACTN2 | physical | 28514442 | |
ACTN4_HUMAN | ACTN4 | physical | 28514442 | |
GORS2_HUMAN | GORASP2 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90 AND SER-130, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90 AND SER-130, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186; SER-187; SER-239AND TYR-321, AND MASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90 AND SER-130, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-321, AND MASSSPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-321, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-144 AND TYR-151, ANDMASS SPECTROMETRY. | |
"Robust phosphoproteomic profiling of tyrosine phosphorylation sitesfrom human T cells using immobilized metal affinity chromatography andtandem mass spectrometry."; Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,Peters E.C.; Anal. Chem. 76:2763-2772(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-321, AND MASSSPECTROMETRY. |